Implementing Regulation (EU) 2018/1882, has recently been amended by Commission Implementing Regulation (EU) 2026/169 [Commission Implementing Regulation (EU) 2026/169 of 26 January 2026 amending the Annex to Implementing Regulation (EU) 2018/1882 concerning the categorisation of infection with bluetongue virus (serotypes 1-24) as a listed disease (OJ L, 2026/169, 27.1.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/169/oj).], which applies as of 1 November 2026. Implementing Regulation (EU) 2026/169 has re-categorised infection with bluetongue virus (serotypes 1-24) as a category D+E disease. Such re-categorisation necessitates the amendment of the rules for infection with bluetongue virus (serotypes 1-24) as regards optional eradication programmes, including the requirements for movements of animals when entering into a Member States or zone thereof covered by an eradication programme for the bluetongue virus (serotypes 1-24) laid down in Article 43 of Delegated Regulation (EU) 2020/689. Those amendments to Delegated Regulation (EU) 2020/689 apply from 1 November 2026. Therefore, the requirements related to infection with bluetongue virus (serotypes 1-24) for movements within the Union laid down in Delegated Regulation (EU) 2020/688, also need to be amended from that date.
Recital 6, Regulation (EU) 2026/795
In forcesince 27 Mar 2026